Concordance of PD-L1 expression detection in non-small cell lung cancer (NSCLC) tissue biopsies between OncoTect iO single cell PD-L1 quantification assay and immunohistochemistry (IHC).

Amanda Chargin,Rian Morgan,Bruce K. Patterson

Concordance of PD-L1 expression detection in non-small cell lung cancer (NSCLC) tissue biopsies between OncoTect iO single cell PD-L1 quantification assay and immunohistochemistry (IHC).

2017

Amanda Chargin
Rian Morgan
Bruce K. Patterson

e23172Background: PD-1/PD-L1 therapy has been shown to be effective in patients with NSCLC, specifically those with 50% PD-L1 expression or greater by IHC. Response rates for those with lower PD-L1...

Keywords:

Cell
non-small cell lung cancer (NSCLC)
PD-L1
Pathology
Concordance
Immunohistochemistry
Medicine
pd l1 expression
in patient
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations